Rajah T T, Pento J T
Department of Pharmacology and Toxicology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Cancer Invest. 1999;17(1):10-8.
Metastatic spread of breast cancer is responsible for most of the morbidity and mortality associated with this disease. Thus, it is important to identify agents with antimetastatic activity. Because invasiveness and tumor cell attachment are fundamental steps in the metastatic cascade, the major objective of the present study was to evaluate the antimetastatic potential of three antiestrogens, each with different chemical structure and mechanism of action, on breast cancer cell invasiveness and laminin attachment. The antiestrogens examined were tamoxifen, a mixed antagonist/agonist; Analog II, a cyclopropyl antiestrogen with pure antagonist activity; and ICI-182,780, a steroidal antiestrogen with pure antagonist activity. Our results indicate that MDA-MB-231 human breast cancer cells are much more invasive and have a higher affinity for laminin than do MCF-7 human breast cancer cells. All three antiestrogens, at a concentration of 10(-6) M, produced a reduction in MDA-MB-231 cell invasiveness, which was comparable in magnitude to their inhibition of MDA-MB-231 attachment to laminin. Evaluation of MDA-MB-231 cell morphology using scanning electron microscopy revealed the involvement of cellular pseudopodia and microvilli in the process of invasion. The results of this study suggest that antiestrogen-induced inhibition of breast cancer cell invasiveness could be due in part to a decrease in the attachment of tumor cells to laminin in the basement membrane.
乳腺癌的转移扩散是导致该疾病相关的大部分发病率和死亡率的原因。因此,识别具有抗转移活性的药物很重要。由于侵袭性和肿瘤细胞黏附是转移级联反应中的基本步骤,本研究的主要目的是评估三种具有不同化学结构和作用机制的抗雌激素对乳腺癌细胞侵袭性和层粘连蛋白黏附的抗转移潜力。所检测的抗雌激素分别是他莫昔芬,一种混合拮抗剂/激动剂;类似物II,一种具有纯拮抗剂活性的环丙基抗雌激素;以及ICI-182,780,一种具有纯拮抗剂活性的甾体抗雌激素。我们的结果表明,MDA-MB-231人乳腺癌细胞比MCF-7人乳腺癌细胞更具侵袭性,且对层粘连蛋白具有更高的亲和力。所有三种抗雌激素在浓度为10(-6) M时,均使MDA-MB-231细胞的侵袭性降低,其降低幅度与它们对MDA-MB-231细胞黏附于层粘连蛋白的抑制作用相当。使用扫描电子显微镜对MDA-MB-231细胞形态进行评估,揭示了细胞伪足和微绒毛参与了侵袭过程。本研究结果表明,抗雌激素诱导的乳腺癌细胞侵袭性抑制可能部分归因于肿瘤细胞与基底膜中层粘连蛋白黏附的减少。